Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment

Lee, SR; Choi, H; Lee, BH; Kang, KW; Yu, ES; Kim, DS; Park, Y; Choi, CW; Kim, BS; Sung, HJ

Sung, HJ (reprint author), Korea Univ, Dept Internal Med, Div Hematol & Oncol, Ansan Hosp, 123 Jeokgeum Ro, Ansan 15355, South Korea.

KOREAN JOURNAL OF INTERNAL MEDICINE, 2019; 34 (6): 1333

Abstract

Background/Aims: Bortezomib plus melphalan-prednisone (VMP) is a standard treatment for multiple myeloma, particularly for patients who are ineligible......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索